These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 9235003)
21. Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermia. Bendahan D; Guis S; Monnier N; Kozak-Ribbens G; Lunardi J; Ghattas B; Mattei JP; Cozzone PJ Acta Anaesthesiol Scand; 2004 Sep; 48(8):1019-27. PubMed ID: 15315621 [TBL] [Abstract][Full Text] [Related]
22. Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle. Hartung E; Koob M; Anetseder M; Schoemig P; Krauspe R; Hogrefe G; Engelhardt W Acta Anaesthesiol Scand; 1996 Apr; 40(4):437-44. PubMed ID: 8738688 [TBL] [Abstract][Full Text] [Related]
23. [Malignant hyperthermia of Duchenne muscular dystrophy: application of clinical grading scale and caffeine contracture of skinned muscle fibers]. Takagi A Rinsho Shinkeigaku; 2000 May; 40(5):423-7. PubMed ID: 11002722 [TBL] [Abstract][Full Text] [Related]
24. Ryanodine receptor mutations in malignant hyperthermia and central core disease. McCarthy TV; Quane KA; Lynch PJ Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202 [TBL] [Abstract][Full Text] [Related]
25. Determination of a positive malignant hyperthermia (MH) disposition without the in vitro contracture test in families carrying the RYR1 Arg614Cys mutation. Rueffert H; Olthoff D; Deutrich C; Froster UG Clin Genet; 2001 Aug; 60(2):117-24. PubMed ID: 11553045 [TBL] [Abstract][Full Text] [Related]
26. The Israeli Diagnostic Center for Malignant Hyperthermia: 7-years' accumulated experience. Glauber V; Ben Abraham R; Zweig A; Perel A Isr J Med Sci; 1997 Oct; 33(10):643-7. PubMed ID: 9397136 [TBL] [Abstract][Full Text] [Related]
27. [Theophylline induces contractures in porcine skeletal muscle preparations with the disposition to malignant hyperthermia]. Gerbershagen MU; Fiege M; Weisshorn R; Kolodzie K; Wappler F Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Mar; 39(3):147-52. PubMed ID: 15042504 [TBL] [Abstract][Full Text] [Related]
28. Results of in vitro contracture testing of both parents of malignant hyperthermia susceptible probands. Islander G; Bendixen D; Ranklev-Twetman E; Ording H Acta Anaesthesiol Scand; 1996 May; 40(5):579-84. PubMed ID: 8792888 [TBL] [Abstract][Full Text] [Related]
29. Is there a link between exertional heat stroke and susceptibility to malignant hyperthermia? Sagui E; Montigon C; Abriat A; Jouvion A; Duron-Martinaud S; Canini F; Zagnoli F; Bendahan D; Figarella-Branger D; Brégigeon M; Brosset C PLoS One; 2015; 10(8):e0135496. PubMed ID: 26258863 [TBL] [Abstract][Full Text] [Related]
30. [High purity ryanodine for in vitro diagnosis of malignant hyperthermia]. Wappler F; Roewer N; Lenzen C; Scholz J; Steinfath M; Rumberger R; Schulte am Esch J Anasthesiol Intensivmed Notfallmed Schmerzther; 1993 Nov; 28(7):427-31. PubMed ID: 8297948 [TBL] [Abstract][Full Text] [Related]
31. [Diagnosis of susceptibility to malignant hyperthermia in children]. Krivosic-Horber R; Adnet P; Krivosic I; Reyford H Arch Fr Pediatr; 1990; 47(6):421-4. PubMed ID: 2403268 [TBL] [Abstract][Full Text] [Related]
32. Failure of the platelet-halothane nucleotide depletion test as a diagnostic or screening test for malignant hyperthermia. Britt BA; Scott EA Anesth Analg; 1986 Feb; 65(2):171-5. PubMed ID: 3942305 [TBL] [Abstract][Full Text] [Related]
34. Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. McCarthy TV; Healy JM; Heffron JJ; Lehane M; Deufel T; Lehmann-Horn F; Farrall M; Johnson K Nature; 1990 Feb; 343(6258):562-4. PubMed ID: 2300206 [TBL] [Abstract][Full Text] [Related]
35. An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot study. Schuster F; Metterlein T; Negele S; Kranke P; Muellenbach RM; Schwemmer U; Roewer N; Anetseder M Anesth Analg; 2008 Sep; 107(3):909-14. PubMed ID: 18713904 [TBL] [Abstract][Full Text] [Related]
36. A case of discordance between genotype and phenotype in a malignant hyperthermia family. Fortunato G; Carsana A; Tinto N; Brancadoro V; Canfora G; Salvatore F Eur J Hum Genet; 1999; 7(4):415-20. PubMed ID: 10352931 [TBL] [Abstract][Full Text] [Related]
37. Diagnosis of malignant hyperthermia: a comparison of the in vitro contracture test with the molecular genetic diagnosis in a large pedigree. Healy JM; Quane KA; Keating KE; Lehane M; Heffron JJ; McCarthy TV J Med Genet; 1996 Jan; 33(1):18-24. PubMed ID: 8825043 [TBL] [Abstract][Full Text] [Related]
38. [Effects of serotonin 2 receptor agonists on skeletal muscle preparations in patients with a disposition toward malignant hyperthermia]. Wappler F; Roewer N; Köchling A; Scholz J; Steinfath M; Rumberger E; Löscher W; Schulte am Esch J Anaesthesist; 1995 Aug; 44(8):538-44. PubMed ID: 7573901 [TBL] [Abstract][Full Text] [Related]
40. [A new emphasis on the diagnosis of malignant hyperthermia using the in vitro contracture test?]. Olthoff D; Meinecke CD Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):454-8. PubMed ID: 1786305 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]